Argent Biopharma Limited has released a press release.
Patent application lodged for novel drug delivery system
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- 1St patient recruited into cimetra phase 3 clinical trial
- Cannepil available for free dispensing in ireland
- Mgc pharma 2021 clinical trials program update
- Cimetra patent submitted to european ip office
- Further findings on artemic as anti-inflammatory agent
Later from Argent Biopharma
- Mgc pharma executes US$24M US supply agreement
- Cimetra import approval granted for india
- Uk import permit granted for cannepil
- Artemic eu sale approval and clinical trial update
- First order received under US supply agreement
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma